Oramed Pharmaceuticals Inc. (ORMP) earnings

  • Healthcare
  • NASDAQ
  • Market cap$155M

Latest result

9 days ago

⁦0.0%⁩EPS Inline

2026-11-12Q3 FY2026
EPS
Reported / estimate0.43 / 0.43

Stock reaction

Unavailable

Next report

No scheduled report date right now.

Recent quarters

Latest 12 quarters

Reported / estimate

  • Q3 FY2026 · 2026-11-12Unavailable
    EPS0.43 / 0.430.0%
    Revenue— / —
  • Q2 FY2026 · 2026-08-10Unavailable
    EPS2.76 / 0.43+541.9%‡
    Revenue— / —
  • Q1 FY2026 · 2026-05-19Unavailable
    EPS-0.16 / ——
    Revenue— / —
  • Q4 FY2025 · 2026-03-26Unavailable
    EPS-0.06 / -0.08+$0.02*
    Revenue— / $500K
  • Q3 FY2025 · 2025-11-13Unavailable
    EPS1.13 / -0.04+$1.17*
    Revenue— / —
  • Q2 FY2025 · 2025-08-14Unavailable
    EPS-0.05 / -0.04-$0.01*
    Revenue— / —
  • Q1 FY2025 · 2025-05-15Unavailable
    EPS-0.19 / -0.03-$0.16*
    Revenue$2.00M / —
  • Q4 FY2024 · 2025-03-27Unavailable
    EPS0.01 / -0.03+$0.04*
    Revenue— / —
  • Q3 FY2024 · 2024-11-07Unavailable
    EPS-0.48 / -0.00-$0.48*
    Revenue— / —
  • Q2 FY2024 · 2024-08-14Unavailable
    EPS0.26 / 0.01+$0.25*
    Revenue— / $250K
  • Q1 FY2024 · 2024-05-09Unavailable
    EPS0.04 / 0.02+$0.02*
    Revenue— / $500K
  • Q4 FY2023 · 2024-03-06Unavailable
    EPS-0.08 / -0.12+33.3%
    Revenue— / —
  • ‡A surprise beyond ±100% is usually a one-off item or a different basis, so it is left out of averages
  • *The estimate is under $0.10, so a percentage misleads; the gap is shown in dollars
  • Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.